Why is perioperative chemotherapy for bladder cancer underutilized?

Patafio, Francis M; Mackillop, William J; Feldman-Stewart, Deb; Siemens, David Robert; Booth, Christopher M

Patafio, Francis M; Mackillop, William J; Feldman-Stewart, Deb; Siemens, David Robert; Booth, Christopher M.

Afiliação

Patafio FM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
Mackillop WJ; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
Feldman-Stewart D; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
Siemens DR; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
Booth CM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada. Electronic address: boothc@kgh.kari.net.

Urol Oncol ; 32(4): 391-5, 2014 May.

Article em En | MEDLINE | ID: mdl-24508282

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Assistência Perioperatória/estatística & dados numéricos; Neoplasias da Bexiga Urinária/tratamento farmacológico; Quimioterapia Adjuvante; Humanos

Palavras-chave

bladder cancer; chemotherapy; health policy; knowledge translation; medical decision making; practice patterns; quality of care

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Protocolos de Quimioterapia Combinada Antineoplásica / Assistência Perioperatória Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google